FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dah Ho

Research Profile

Disorders

Procedures

Microbial Sensitivity Tests

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Yun Lin; Dah H Ho; Robert A Newman
Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunitst.
Yun Lin; William P Dubinsky; Dah H Ho; Edward Felix; Robert A Newman
Determinants of human and mouse melanoma cell sensitivities to oleandrin.
Kenneth V I Rolston; Davood Yadegarynia; Dimitrios P Kontoyiannis; Issam I Raad; Dah H Ho
The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dah Ho (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Yun Lin; Dah H Ho; Robert A Newman
Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunitst.
Journal of experimental therapeutics & oncology 2010;8(4):271-86.
2008: Yun Lin; William P Dubinsky; Dah H Ho; Edward Felix; Robert A Newman
Determinants of human and mouse melanoma cell sensitivities to oleandrin.
Journal of experimental therapeutics & oncology 2008;7(3):195-205.
2006: Kenneth V I Rolston; Davood Yadegarynia; Dimitrios P Kontoyiannis; Issam I Raad; Dah H Ho
The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2006;10(3):223-30.
2006: Robert A Newman; Peiying Yang; Walter N Hittelman; Tao Lu; Dah H Ho; Dan Ni; Diana Chan; Mary Vijjeswarapu; Carrie Cartwright; Susan Dixon; Edward Felix; Crandell Addington
Oleandrin-mediated oxidative stress in human melanoma cells.
Journal of experimental therapeutics & oncology 2006;5(3):167-81.
2003: Kenneth V I Rolston; Susan Frisbee-Hume; Barbara M LeBlanc; Harriet Streeter; Dah H Ho
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients.
Diagnostic microbiology and infectious disease 2003;47(2):441-9.
2003: Dan Ni; Dah H Ho; Mary Vijjeswarapu; Edward Felix; P Robyn Rhea; Robert A Newman
Metabolism of homoharringtonine, a cytotoxic component of the evergreen plant Cephalotaxus harringtonia.
Journal of experimental therapeutics & oncology 2003;3(1):47-52.
2002: Kenneth V I Rolston; Susan Frisbee-Hume; Barbara M LeBlanc; Harriet Streeter; Dah H Ho
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
Diagnostic microbiology and infectious disease 2002;44(2):187-94.
2002: Dan Ni; Timothy L Madden; Mary Johansen; Edward Felix; Dah H Ho; Robert A Newman
Murine pharmacokinetics and metabolism of oleandrin, a cytotoxic component of Nerium oleander.
Journal of experimental therapeutics & oncology 2002;2(5):278-85.
2002: Kenneth V I Rolston; Barbara M LeBlanc; Harriet Streeter; Dah H Ho
In vitro activity of ertapenem against bacterial isolates from cancer patients.
Diagnostic microbiology and infectious disease 2002;43(3):219-23.
2000: Dah H Ho; W Covington; N Brown; S N Lin; Richard Pazdur; Y Y Huo; Patrick J Creaven; Youcef M Rustum; Neal J Meropol; Yvonne Lassere; Jun Kuritani; T Hayakawa
Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer.
Cancer chemotherapy and pharmacology 2000;46(5):351-6.
1999: K Jacobson; Kenneth Rolston; Linda S Elting; Barbara M LeBlanc; Estella E Whimbey; Dah H Ho
Susceptibility surveillance among gram-negative bacilli at a cancer center.
Chemotherapy 1999;45(5):325-34.
1998: Dah H Ho; Richard Pazdur; W Covington; N Brown; Y Y Huo; Yvonne Lassere; Jun Kuritani
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2085-8.
1998: Richard Pazdur; Yvonne Lassere; EA Diaz-Canton; Dah H Ho
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
Cancer investigation 1998;16(3):145-51.
1997: Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; Harriet Streeter; Tanya Dvorak
In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
The Journal of antimicrobial chemotherapy 1997;39 Suppl B():15-22.
1997: Richard Pazdur; Yvonne Lassere; EA Diaz-Canton; B Bready; Dah H Ho
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.
Investigational new drugs 1997;15(2):123-8.
1996: Richard Pazdur; Yvonne Lassere; EA Diaz-Canton; B Bready; Dah H Ho
Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule-dependent toxicities.
Anti-cancer drugs 1996;7(7):728-33.
1996: Kenneth V I Rolston; Linda S Elting; S Waguespack; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center.
Chemotherapy 1996;42(5):348-53.
1996: Kenneth V I Rolston; N Dholakia; Dah H Ho; Barbara M LeBlanc; T Dvorak; H Streeter
In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
The Journal of antimicrobial chemotherapy 1996;38(2):265-9.
1995: J R Lin; I Bekersky; N S Brown; S Mong; F Lee; Robert A Newman; Dah H Ho
Normocalcemic effect of gallium nitrate in a hypercalcemic rat model.
Cancer research 1995;55(2):307-11.
1994: N Dholakia; Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; H Streeter; T Dvorak; Gerald P Bodey
In vitro activity of FK-037, a novel parenteral cephalosporin, against bacterial isolates from neutropenic cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(8):679-85.
1994: N Dholakia; Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.
Antimicrobial agents and chemotherapy 1994;38(4):848-52.
1994: J R Lin; N S Brown; Robert A Newman; Dah H Ho
Determination of peplomycin in mouse tissues and biofluids by radioimmunoassay.
Journal of pharmaceutical and biomedical analysis 1994;12(2):145-50.
1993: Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.
Antimicrobial agents and chemotherapy 1993;37(11):2504-5.
1993: Dah H Ho; Richard Pazdur; N S Brown; W P Covington; Martin N Raber; I H Krakoff
Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973).
Anticancer research 1993;13(2):343-6.
1993: Dah H Ho; W P Covington; R O Wallerstein; Jeane Hester; J R Lin; N S Brown; Robert A Newman; I H Krakoff; E J Freireich
Depletion of patients' plasma tryptophan using tryptophan side-chain oxidase columns.
Cancer investigation 1993;11(3):252-7.
1993: Michael J Keating; R Holmes; Susan Lerner; Dah H Ho
L-asparaginase and PEG asparaginase--past, present, and future.
Leukemia & lymphoma 1993;10 Suppl():153-7.
1992: Dah H Ho; W P Covington; Richard Pazdur; N S Brown; J Kuritani; Robert A Newman; Martin N Raber; I H Krakoff
Clinical pharmacology of combined oral uracil and ftorafur.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(6):936-40.
1992: K Fang; Charles Koller; N Brown; W Covington; J R Lin; Dah H Ho
Determination of plicamycin in plasma by radioimmunoassay.
Therapeutic drug monitoring 1992;14(3):255-60.
1992: Kenneth V I Rolston; H T Nguyen; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
Antimicrobial agents and chemotherapy 1992;36(4):879-82.
1991: Richard Pazdur; Dah H Ho; K Daugherty; W T Bradner; I H Krakoff; Martin N Raber
Phase I trial of FK973: description of a delayed vascular leak syndrome.
Investigational new drugs 1991;9(4):377-82.
1991: Dah H Ho; N Brown; J R Lin; W Covington; Robert A Newman; Martin N Raber; R Amato; S Schmidt; I H Krakoff
Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.
Drug metabolism and disposition: the biological fate of chemicals 1991;19(3):643-7.
1990: Kenneth V I Rolston; H Nguyen; M Messer; Barbara M LeBlanc; Dah H Ho; Gerald P Bodey
In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.
Antimicrobial agents and chemotherapy 1990;34(11):2263-6.
1990: Kenneth V I Rolston; M Messer; Dah H Ho
Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer.
Antimicrobial agents and chemotherapy 1990;34(9):1812-3.
1990: Kenneth V I Rolston; Barbara M LeBlanc; Dah H Ho; Gerald P Bodey
In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
The Journal of antimicrobial chemotherapy 1990;26(1):39-44.
1990: M Uchida; N Brown; Dah H Ho
Enzymatic conversion of 5-fluoro-2'-deoxyuridine to 5-fluorouracil or 5-fluoro-2'-deoxyuridine 5'-monophosphate in human tissues.
Anticancer research 1990;10(3):779-83.
1990: Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.
Chemotherapy 1990;36(5):365-72.
1990: Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(1):30-3.
1989: M S Engineer; N S Brown; Dah H Ho; Robert A Newman; R E Bulger
A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats.
Toxicology 1989;59(2):151-62.
1989: Dah H Ho; W P Covington; J Lin; N S Brown; Robert A Newman
Metabolism and disposition of (R)-4-[3-(2-hydroxy-2-phenyl)ethylamino-3-methylbutyl]benzamide Hcl (LY 195448) in rodents.
Research communications in chemical pathology and pharmacology 1989;66(2):255-67.
1989: A Reuben; E Anaissie; P E Nelson; R Hashem; C Legrand; Dah H Ho; Gerald P Bodey
Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.
Antimicrobial agents and chemotherapy 1989;33(9):1647-9.
1989: Gerald P Bodey; P Miller; Dah H Ho
In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients.
Diagnostic microbiology and infectious disease 1989;12(4 Suppl):209S-214S.
1989: Kenneth V I Rolston; Barbara M LeBlanc; G Gooch; Dah H Ho; Gerald P Bodey
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
The Journal of antimicrobial chemotherapy 1989;23(3):363-71.
1989: Kenneth Rolston; Dah H Ho; Gerald P Bodey
In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(3):254-60.
1988: Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; G Gooch; Gerald P Bodey
Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(5):684-6.
1988: Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(5):681-3.
1988: Gerald P Bodey; Dah H Ho; Linda S Elting
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
The American journal of medicine 1988;85(1A):49-51.
1988: Kenneth Rolston; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Chemotherapy 1988;34(6):448-54.
1988: Dah H Ho; C Y Wang; J R Lin; N Brown; Robert A Newman; I H Krakoff
Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.
Drug metabolism and disposition: the biological fate of chemicals 1988;16(1):27-9.
1987: M S Engineer; Dah H Ho; Abdul R Khokhar; Robert A Newman; R E Bulger
A comparison of the effects of cisplatin and N-methyliminodiacetato-(1,2-diaminocyclohexane)-platinum(II) on renal function and gentamicin excretion in rats.
Toxicology 1987;47(3):307-15.
1987: H Saito; Kenneth V I Rolston; Dah H Ho; Barbara M LeBlanc; Gerald P Bodey
In-vitro activity of LY146032 against gram-positive isolates from cancer patients.
The Journal of antimicrobial chemotherapy 1987;20(4):497-503.
1987: G Samonis; Dah H Ho; G F Gooch; Kenneth V I Rolston; Gerald P Bodey
In vitro susceptibility of Citrobacter species to various antimicrobial agents.
Antimicrobial agents and chemotherapy 1987;31(5):829-30.
1987: M S Engineer; Gerald P Bodey; Robert A Newman; Dah H Ho
Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats.
Drug metabolism and disposition: the biological fate of chemicals 1987;15(3):329-34.
1987: K V Rolston; Dah H Ho; B LeBlanc; Gerald P Bodey
In vitro evaluation of difloxacin (A-56619), A-56620, and other 4-quinolones against isolates from cancer patients.
Chemotherapy 1987;33(6):419-27.
1986: Kenneth V I Rolston; M E Alvarez; J F Hoy; H C Alderman; Dah H Ho; Gerald P Bodey
In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients.
The Journal of antimicrobial chemotherapy 1986;18(2):159-62.
1986: Dah H Ho; N S Brown; A Yen; R Holmes; M Keating; A Abuchowski; Robert A Newman; I H Krakoff
Clinical pharmacology of polyethylene glycol-L-asparaginase.
Drug metabolism and disposition: the biological fate of chemicals 1986;14(3):349-52.
1986: Kenneth Rolston; M E Alvarez; J F Hoy; Barbara M LeBlanc; Dah H Ho; Gerald P Bodey
Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients.
Chemotherapy 1986;32(4):344-51.
1986: Kenneth V I Rolston; M E Alvarez; J F Hoy; H C Alderman; Dah H Ho; Gerald P Bodey
In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.
Chemotherapy 1986;32(6):506-14.
1986: A Uematsu; Dah H Ho; B Drewinko; L Y Yang; N S Brown; Gerald P Bodey; I H Krakoff
Peplomycin and bleomycin effects on human colon cancer cells.
Anticancer research 1986;6(1):1-3.
1981: M S Engineer; Dah H Ho; Gerald P Bodey
Comparison of vancomycin disposition in rats with normal and abnormal renal functions.
Antimicrobial agents and chemotherapy 1981;20(6):718-22.